Morgan Stanley
CORZ icon

Morgan Stanley’s Core Scientific CORZ Stock Holding History

Morgan Stanley’s Portfolio CORZ Stock Details CORZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$162M Buy
6,338,943
+2,866,937
+83% +$67.5M 0.01% 1182
2026
Q1 		$51.9M Buy
3,472,006
+133,579
+4% +$2.28M ﹤0.01% 2062
2025
Q4 		$48.6M Buy
3,338,427
+1,922,277
+136% +$33.5M ﹤0.01% 2106
2025
Q3 		$25.4M Sell
1,416,150
-388,319
-22% -$5.7M ﹤0.01% 2657
2025
Q2 		$30.8M Sell
1,804,469
-631,414
-26% -$6.32M ﹤0.01% 2383
2025
Q1 		$17.6M Sell
2,435,883
-908,251
-27% -$10.3M ﹤0.01% 2816
2024
Q4 		$47M Buy
3,344,134
+1,742,279
+109% +$25.7M ﹤0.01% 1887
2024
Q3 		$19M Buy
1,601,855
+757,604
+90% +$7.85M ﹤0.01% 2847
2024
Q2 		$7.85M Buy
844,251
+748,064
+778% +$3.82M ﹤0.01% 3507
2024
Q1 		$341K Buy
+96,187
New +$334K ﹤0.01% 5499

Other funds holding CORZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SA
Situational Awareness San Francisco, California $20.2B AUM 612.59% 1-Year Est. Return
JCAM
Jericho Capital Asset Management New York $12.1B AUM 109.57% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VARA
Value Aligned Research Advisors Princeton, New Jersey $40.1B AUM 376.19% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return

Morgan Stanley's CORZ Position: Q2 2026 in Review

Morgan Stanley increased its Core Scientific (CORZ) stake by 83% in Q2 2026, buying an estimated $67.5M and bringing the position to 6,338,943 shares worth $162M. The position accounts for 0.01% of the portfolio, ranked #1182.

Morgan Stanley first reported a position in CORZ in Q1 2024 and has held it in 10 quarters since. 413 funds tracked by Wall St. Rank hold CORZ as of Q2 2026.

  • Morgan Stanley held 6,338,943 shares of Core Scientific worth $162M as of Q2 2026.
  • Morgan Stanley bought 2,866,937 Core Scientific shares in Q2 2026, an estimated $67.5M.
  • Core Scientific made up 0.01% of Morgan Stanley's portfolio in Q2 2026, its #1182 holding.
  • Morgan Stanley first reported a position in Core Scientific in Q1 2024 and has held it in 10 quarters since.
  • 413 funds tracked by Wall St. Rank held Core Scientific as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.